DOI: 10.11607/prd.1737, PubMed-ID: 25006772Seiten: 550-557, Sprache: EnglischEdmunds, Ryan K. / Mealey, Brian L. / Mills, Michael P. / Thoma, Daniel S. / Schoolfield, John / Cochran, David L. / Mellonig, JimNo human studies exist on the use of recombinant human bone morphogenetic protein 2 (rhBMP-2) on an absorbable collagen sponge (ACS) as a sole graft material for lateral ridge augmentation in large ridge defect sites. This series evaluates the treatment outcome of maxillary anterior lateral ridge augmentation with rhBMP-2/ACS. Twenty patients were treated with rhBMP-2/ACS and fixation screws for space maintenance. Cone beam volumetric tomography measurements were used to determine gain in ridge width, and a bone core biopsy was obtained. The mean horizontal ridge gain was 1.2 mm across sites, and every site gained width.
